Target intelligence / Profile preview

Calcium-transporting ATPase (Usually abbreviated as SERCA for sarco(endo)plasmic reticulum Ca2+-ATPases, PMCA for plasma membrane Ca2+-ATPases)

Target
Usually abbreviated as SERCA for sarco(endo)plasmic reticulum Ca2+-ATPases, PMCA for plasma membrane Ca2+-ATPases
Molecular classification
Enzyme, Transporter, P-type ATPase (primary active transporter protein superfamily), Ion pump
01

Overview

Calcium-transporting ATPases are a family of integral membrane proteins responsible for transport of Ca2+ ions against their concentration gradient, using energy derived from ATP hydrolysis. The main subtypes are **SERCA** (resides in sarco/endoplasmic reticulum, critical for muscle contraction and relaxation), **PMCA** (resides in the plasma membrane, extrudes Ca2+ to maintain low cytosolic concentrations), and **SPCA** (located in secretory pathway organelles)[7][1][2][3][6]. These pumps play central roles in cell signaling, muscle function, neurotransmitter release, and hormone secretion. Structurally, they undergo complex conformational changes during transport cycles, coupling ATP hydrolysis with Ca2+ binding and release, and are regulated by proteins such as calmodulin[8]. Dysregulation or genetic mutations affecting these ATPases are implicated in cardiovascular, muscular, neurological, and other diseases, making them critical therapeutic and research targets[6][1].

Other names
Sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA)Plasma membrane Ca2+-ATPase (PMCA)Secretory pathway Ca2+-ATPase (SPCA)Ca2+ pumpCalcium pump
02

Mechanism of action

Inhibition (drugs like thapsigargin block ATPase function, inducing calcium overload and cell death); Modulation (potential for enhancing SERCA activity in heart failure or suppressing PMCA in certain cancers)

03

Biological functions

Regulation of cytoplasmic calcium concentrationCell signalingMuscle contraction/relaxation (particularly SERCA)Maintenance of membrane potentialSecretory pathway calcium loading (SPCA)Apoptosis (indirectly via calcium overload)
04

Disease associations

Cardiovascular disease (e.g., heart failure; SERCA dysfunction impairs cardiac relaxation)Muscle diseases (e.g., muscle fatigue, myopathies)Neurodegenerative disease (due to calcium dysregulation)Metabolic disease (altered calcium signaling)Cancer (certain isoforms involved in proliferation/apoptosis)Other: deafness (mutation in SPCA1), skin disorders
05

Safety considerations

Risk of arrhythmias (altered calcium homeostasis in heart)Muscle weakness or paralysisNeurotoxicity (from dysregulated calcium signaling)Potential for off-target cell death (if broadly inhibiting calcium pumps)
06

Interacting drugs

Thapsigargin (SERCA inhibitor, used experimentally and in some cancer therapies)

3 more in the full profile.

07

Biomarkers

SERCA expression levels (heart failure, muscle diseases)PMCA isoform expression (various tissue-specific pathologies)Ca2+ imaging (functional readout of ATPase action)No universally accepted circulating biomarker for patient selection.

Beyond the preview

Go deeper on Calcium-transporting ATPase (Usually abbreviated as SERCA for sarco(endo)plasmic reticulum Ca2+-ATPases, PMCA for plasma membrane Ca2+-ATPases).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium-transporting ATPase (Usually abbreviated as SERCA for sarco(endo)plasmic reticulum Ca2+-ATPases, PMCA for plasma membrane Ca2+-ATPases).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call